Back
Carvana Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
56
CVNA
Carvana
Last Price:
169.72
Seasonality Move:
-5.14%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
Buy
56
Carvana (CVNA)
is a Buy
Is Carvana a Buy, Sell or Hold?
- The current Carvana [CVNA] share price is $169.78. The Score for CVNA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- CVNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVNA Stock Price Chart
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
CVNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.83 | Buy |
| Relative Strength Index (14 RSI): | 64.01 | Buy |
| Chaikin Money Flow: | -473264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.18 - 167.96) | Buy |
| Bollinger Bands (100): | (112.35 - 151.33) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.18 | Sell |
| Relative Strength Index (14 RSI): | 35.54 | Sell |
| Chaikin Money Flow: | -49995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.27 - 135.95) | Sell |
| Bollinger Bands (100): | (123.89 - 147.49) | Sell |
CVNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 170.59 | Sell |
| 20-day SMA: | 153.54 | Buy |
| 50-day SMA: | 146.26 | Buy |
| 200-day SMA: | 98.83 | Buy |
| 8-day EMA: | 167.52 | Buy |
| 20-day EMA: | 159.04 | Buy |
| 50-day EMA: | 147.43 | Buy |
| 200-day EMA: | 107.27 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.45 | Sell |
| 20-day SMA: | 127.75 | Sell |
| 50-day SMA: | 135.2 | Sell |
| 200-day SMA: | 127.53 | Sell |
| 8-day EMA: | 125.39 | Sell |
| 20-day EMA: | 128.04 | Sell |
| 50-day EMA: | 132.59 | Sell |
| 200-day EMA: | 128.64 | Sell |
Carvana Earnings Growth & CVNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.09 per share, an increase next quarter of $0.20 per share, an increase this year of $1.98 per share, and an increase next year of $0.71 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Carvana Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||